Previous close | 131.91 |
Open | 131.72 |
Bid | 131.33 x 400 |
Ask | 131.44 x 400 |
Day's range | 130.16 - 132.22 |
52-week range | 74.75 - 142.00 |
Volume | |
Avg. volume | 2,930,206 |
Market cap | 52.24B |
Beta (5Y monthly) | 1.22 |
PE ratio (TTM) | 85.30 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
Matthew Dolan, Executive Vice President of Strategy and Corporate Development at DexCom Inc (NASDAQ:DXCM), sold 2,423 shares of the company on May 15, 2024.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.